Loading viewer...
conference
Format: PDF conference
Repligen CEO Tony Hunt presents at the 42nd J.P. Morgan Healthcare Conference, discussing bioprocessing market recovery and the company's innovation leadership in single-use manufacturing technologies. Highlights include improved order funnel, new product launches, and positioning 2024 as a turning point with anticipated growth recovery in 2025.
conference
31 Pages
American Electric Power Company